A 38-year-old woman presents with menorrhagia and dysmenorrhea for 18 months. On examination, the uterus is enlarged to 12 weeks size with irregular contours. Transvaginal ultrasound confirms multiple intramural fibroids, the largest being 4 cm, with no submucosal component. She desires future fertility and wishes to preserve her uterus. What is the most appropriate next step in management?

Explanation

## Clinical Context This patient has symptomatic intramural fibroids with a desire to preserve fertility. The key clinical features are: - Menorrhagia and dysmenorrhea (symptoms of intramural fibroids) - Uterus enlarged to 12 weeks size - Largest fibroid 4 cm (moderate size) - **No submucosal component** (rules out hysteroscopic myomectomy) - **Desire for future fertility** (rules out hysterectomy) ## Management Algorithm for Symptomatic Fibroids with Fertility Desire ```mermaid flowchart TD A[Symptomatic fibroid uterus]:::outcome --> B{Desire for fertility?}:::decision B -->|No| C[Hysterectomy or UAE]:::action B -->|Yes| D{Fibroid location & size?}:::decision D -->|Submucosal| E[Hysteroscopic myomectomy]:::action D -->|Intramural/subserosal| F[Myomectomy: open or laparoscopic]:::action D -->|Multiple large fibroids| G[Consider GnRH agonist pre-op]:::action F --> H[Preserve uterus & fertility]:::outcome ``` ## Why Myomectomy Is Correct **Key Point:** Myomectomy is the gold standard for symptomatic fibroids in women desiring fertility preservation. It removes the fibroid(s) while preserving the uterus and reproductive potential. **High-Yield:** The choice of approach depends on: - **Laparoscopic myomectomy:** 1–3 intramural/subserosal fibroids, <4 cm, no deep intramural extension - **Open myomectomy (laparotomy):** Multiple fibroids, large size (>4 cm), or deep intramural location requiring extensive dissection In this case, the patient has multiple intramural fibroids with the largest being 4 cm. Laparotomy or laparoscopy (depending on surgeon expertise and number/depth of fibroids) is appropriate. **Clinical Pearl:** GnRH agonists may be used **preoperatively** (not as primary therapy) in selected cases to reduce fibroid size and blood loss, but they are not first-line for fertility-desiring women because prolonged use causes hypoestrogenia and does not prevent fibroid recurrence. ## Role of GnRH Agonists GnRH agonists (e.g., leuprolide, goserelin) are indicated for: - Preoperative downsizing of large fibroids (3–6 months) - Temporary symptom relief in perimenopausal women awaiting menopause - NOT as definitive therapy in reproductive-age women (high recurrence after cessation) ## Why Other Options Are Suboptimal | Option | Why Not Appropriate | |--------|---------------------| | **Total abdominal hysterectomy** | Eliminates future fertility; patient explicitly desires to preserve uterus | | **GnRH agonist therapy alone** | Temporary measure; fibroids recur in >50% after cessation; not definitive for fertility-desiring women | | **Uterine artery embolization (UAE)** | Relative contraindication in women desiring future pregnancy (risk of placental insufficiency, preterm labor, cesarean delivery); myomectomy is preferred | **Warning:** Do not confuse GnRH agonist as primary therapy with GnRH agonist as preoperative adjunct. In this case, the patient has moderate-sized fibroids and is symptomatic — surgery is indicated now, not hormonal therapy alone.